TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
SPS Pharma Solutions AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
712,158
|
633,791
|
609,905 |
| Financial expenses |
3,260
|
5,512
|
5,764 |
| Earnings before taxes |
70,786
|
-23,552
|
16,884 |
| EBITDA |
95,152
|
8,160
|
44,658 |
| Total assets |
701,833
|
637,026
|
546,972 |
| Current assets |
406,855
|
345,601
|
279,217 |
| Current liabilities |
185,434
|
217,313
|
193,734 |
| Equity capital |
457,313
|
402,160
|
330,652 |
| - share capital |
10,000
|
10,000
|
10,000 |
| Employees (average) |
306
|
322
|
312 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
65.2%
|
63.1%
|
60.5% |
| Turnover per employee |
2,327
|
1,968
|
1,955 |
| Profit as a percentage of turnover |
9.9%
|
-3.7%
|
2.8% |
| Return on assets (ROA) |
10.6%
|
-2.8%
|
4.1% |
| Current ratio |
219.4%
|
159.0%
|
144.1% |
| Return on equity (ROE) |
15.5%
|
-5.9%
|
5.1% |
| Change turnover |
78,367
|
23,886
|
132,044 |
| Change turnover % |
12%
|
4%
|
28% |
| Chg. No. of employees |
-16
|
10
|
34 |
| Chg. No. of employees % |
-5%
|
3%
|
12% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.